Zhan Y - Search Results

1

Aptamer-polymer functionalized silicon nanosubstrates for enhanced recovered circulating tumor cell viability and in vitro chemosensitivity testing.

Shen Q, Peng C, Zhan Y, Fan L, Wang M, Zhou Q, Liu J, Lv X, Tang Q, Li J, Huang X, Xia J. Shen Q, et al. Among authors: zhan y. Int J Nanomedicine. 2016 May 18;11:2133-46. doi: 10.2147/IJN.S103569. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27274239 Free PMC article.

2

MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1.

Jiang J, Lv X, Fan L, Huang G, Zhan Y, Wang M, Lu H. Jiang J, et al. Among authors: zhan y. Tumour Biol. 2014 Oct;35(10):10019-23. doi: 10.1007/s13277-014-2294-1. Epub 2014 Jul 11. Tumour Biol. 2014. PMID: 25012245

3

The Role of the Key Differentially Mutated Gene FGFR3 in the Immune Microenvironment of Bladder Cancer.

Jiang J, Zhan Y, Li J. Jiang J, et al. Among authors: zhan y. J Immunol Res. 2022 Aug 12;2022:7952706. doi: 10.1155/2022/7952706. eCollection 2022. J Immunol Res. 2022. PMID: 35991125 Free PMC article.

4

Reprogramming the tumor microenvironment by genome editing for precision cancer therapy.

Liu K, Cui JJ, Zhan Y, Ouyang QY, Lu QS, Yang DH, Li XP, Yin JY. Liu K, et al. Among authors: zhan y. Mol Cancer. 2022 Apr 11;21(1):98. doi: 10.1186/s12943-022-01561-5. Mol Cancer. 2022. PMID: 35410257 Free PMC article. Review.

5

Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals.

Wang Y, Xiao F, Chen Y, Xiao LD, Wang LY, Zhan Y, Xiong XL, Zhou G, Liu R, Ouyang DS, Li Z, McLeod HL, Zhang W, Li Q, Liu ZQ, Zhou HH, Yin JY. Wang Y, et al. Among authors: zhan y. Clin Transl Med. 2021 Nov;11(11):e586. doi: 10.1002/ctm2.586. Clin Transl Med. 2021. PMID: 34841710 Free PMC article. No abstract available.

6

COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19.

Zhan Y, Li XP, Yin JY. Zhan Y, et al. Int J Biol Sci. 2021 May 13;17(8):2080-2088. doi: 10.7150/ijbs.60655. eCollection 2021. Int J Biol Sci. 2021. PMID: 34131407 Free PMC article. Review.

7

Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study.

Nie L, Dai K, Wu J, Zhou X, Hu J, Zhang C, Zhan Y, Song Y, Fan W, Hu Z, Yang H, Yang Q, Wu D, Li F, Li D, Nie R. Nie L, et al. Among authors: zhan y. Thorac Cancer. 2021 Jan;12(1):57-65. doi: 10.1111/1759-7714.13710. Epub 2020 Nov 3. Thorac Cancer. 2021. PMID: 33142039 Free PMC article.

8

Sequential Whole Exome Sequencing Reveals Somatic Mutations Associated with Platinum Response in NSCLC.

Guo AX, Xiao F, Shao WH, Zhan Y, Zhang L, Xiong J, Gao Y, Yin JY. Guo AX, et al. Among authors: zhan y. Onco Targets Ther. 2020 Jul 3;13:6485-6496. doi: 10.2147/OTT.S254747. eCollection 2020. Onco Targets Ther. 2020. PMID: 32753889 Free PMC article.

9

B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies.

Zhan Y, Yin H, Yin JY. Zhan Y, et al. Int J Biol Sci. 2022 Feb 14;18(5):1844-1851. doi: 10.7150/ijbs.66881. eCollection 2022. Int J Biol Sci. 2022. PMID: 35342345 Free PMC article. Review.

10

Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatment.

Liu K, Ouyang QY, Zhan Y, Yin H, Liu BX, Tan LM, Liu R, Wu W, Yin JY. Liu K, et al. Among authors: zhan y. Mol Ther Nucleic Acids. 2022 Apr 6;28:464-476. doi: 10.1016/j.omtn.2022.04.001. eCollection 2022 Jun 14. Mol Ther Nucleic Acids. 2022. PMID: 35505958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,569 results

Search Page

Filters